The first zinc(II)-boron(III)-imidazolate porous material Zn(2)(im)Cl(2)[B(im)(4)] (ZBIF-1, im = imidazolate) integrating the structural features of two distinctly different imidazolate frameworks (i.e., ZIFs with the Zn-im linkage and BIFs with B(im)(4)(-) complex) has been realized by utilizing the unique chemistry of deep eutectic solvents.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: